WNK2 and fibrosarcoma: In fibrosarcoma (28) and colorectal cancer (29) cells, the mitogen-activated protein kinase (MAPK) signaling pathway inhibited the expression of VEGF, bFGF and STAT3, and the p38 MAPK signaling pathway mediated VEGF expression in bone marrow mesenchymal stem cells (29).